AASLD: Anti-HCV Drug Boosts Response Rates (CME/CE)

BOSTON (MedPage Today) — Combining the direct anti-viral agent telaprevir with standard hepatitis C care can sharply improve response rates and shorten the treatment period, researchers reported.

Post a Comment

Comments are closed.